Loss of Cxcl9 preserves joint destruction in experimental osteoarthritis
Objectives: Osteoarthritis (OA) represents one of the most common pathologies in orthopedic surgery. However, pharmacologic treatment options are still lacking. Recent clinical studies described increased levels of the chemokine Cxcl9 in the synovial fluid of osteoarthritic knees. This study was thus [for full text, please go to the a.m. URL]
Institutions
- Universität Hamburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Klinik und Poliklinik für Neurologie (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2024-10-21
- DOI
- https://doi.org/10.3205/24dkou069
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00